European Organisation for Research and Treatment of Cancer
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial”.
Salvatore Siena, A. Sartore-Bianchi, Javier Ros, F. Ciardello, E. Martinelli +38 more